|
|
Volumn 10, Issue 6, 2011, Pages 401-402
|
|
The long march of antisense
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALICAFORSEN;
ANTISENSE OLIGONUCLEOTIDE;
APRINOCARSEN;
CUSTIRSEN;
FOMIVIRSEN;
MESSENGER RNA;
MIPOMERSEN;
OBLIMERSEN;
OLIGONUCLEOTIDE PHOSPHOROTHIOATE;
PLACEBO;
ANTISENSE THERAPY;
ARTICLE;
CHRONIC LYMPHATIC LEUKEMIA;
CROHN DISEASE;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG MECHANISM;
DRUG TARGETING;
FAMILIAL HYPERCHOLESTEROLEMIA;
GENE SILENCING;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
MELANOMA;
PHARMACOLOGICAL BLOCKING;
PRIORITY JOURNAL;
PROSTATE CANCER;
RETINITIS;
ANIMALS;
DRUG DELIVERY SYSTEMS;
DRUG DISCOVERY;
DRUG INDUSTRY;
HUMANS;
OLIGONUCLEOTIDES, ANTISENSE;
RNA, ANTISENSE;
|
|
EID: 79957898112
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3474 Document Type: Article |
|
Times cited : (28)
|
|
References (0)
|
